China FDA approves clinical trials for β-aminoarteether maleate for treatment of Lupus erythematosus (SLE)

SLE occurs 10x more often among Asians as compared to Westerners, and 2.2 million people are said tob e infected in China, India and Mexico. β-Aminoarteether maleate is an active ingredient of Artemisia annua.

CAS news release, May 21, 2015

China FDA approves clinical trials for β-aminoarteether maleate for treatment of Lupus erythematosus (SLE)
Scroll to top